|
Parkinson's Disease Update
The Parkinson’s Disease Update is a half-day course designed to support primary care physicians, general neurologists, and advanced practitioners in the care of these patients. Our focus on Parkinson's Disease (PD) management will cover genetics in PD; standard and novel treatments of PD to include medical, surgical, and alternative medications; as well as the timing of referral to a movement disorder specialist or for surgical treatment. The course will conclude with talks on palliativ... |
|
INFORM: Information Needed for Optimal Regulation of Mycophenolate- A REMS Activity
Target Audience
The target audience for this initiative includes obstetricians, gynecologists, primary care physicians, physician assistants, nurse practitioners, pharmacists, and care team members involved in the treatment of women across their reproductive lifespan who may have been prescribed mycophenolate products.
Program Overview
Clinicians who work with women of childbearing age who are, or will be, taking mycophenolate must ensure that their patients receive appropriate counseling... |
|
Delivering Culturally Competent Care: Managing Type 2 Diabetes in Diverse Populations
This course presents practical advice for working cross-culturally. It allows participants to practice and improve their communication skills while managing typical clinical problems encountered in persons with type 2 diabetes.
Outcome Objectives:
As a result of completing this activity, the participant will be better able to:
- Recognize the differences between the terms "race," "ethnicity," and "culture."
- Employ the Ask, Share, Compare, Negotiate Model with patients in the office... |
|
Updates on Pain Review: Conversations with the Experts - Complementary and Alternative Medicine
Learning Objectives:
Review and present a construct for nutraceutical medications.
Provide a framework for further exploration for the consultant pain provider for CAM.
Discuss and review different platforms of CAM.
When preparing to take the pain board examination, both for initial certification and for recertification, there is a dearth of comprehensive educational programming. The Updates on Pain Review: Conversations with the Experts curriculum has been designed to provide the late... |
|
Biosimilars in Osteoporosis: Highlights from the ASBMR
Biosimilars are large, complex molecules made from living organisms that are highly similar to their reference biologic and are administered in the same way, with the same strength and dosage, and clinically meaningful differences in safety, purity, and potency.
Incorporating biosimilars into the management of osteoporosis, known as a silent chronic disease responsible for 13 million fragility fractures worldwide, provide a more affordable version of osteoporosis medication, and an alternat... |